New Bispecific Antibody Redirects T Cells to Attack Melanoma Cells
Researchers at University Hospital Tübingen have engineered NG2-targeting bispecific antibodies that redirect T cells to kill melanoma cells, with a ...
Researchers at University Hospital Tübingen have engineered NG2-targeting bispecific antibodies that redirect T cells to kill melanoma cells, with a ...
A Nature Reviews Cancer review argues that escaping the antiviral viral mimicry response triggered by derepressed transposable elements is a ...
A new study links the hepatitis B virus X protein to tumor-derived MIF signaling that drives CD8-positive T cell exhaustion ...
An armoured GPC3-targeted CAR T cell therapy engineered to resist TGFβ-mediated immunosuppression showed promising initial results in 36 patients with ...
A new Molecular Cancer review proposes immune-pressure redistribution as a unifying framework explaining why patients resist PD-1/PD-L1 blockade and how ...
A systematic review of preclinical studies finds that photodynamic therapy can induce systemic antitumor immunity and abscopal effects, especially when ...
A translational modelling study finds that PD-1 receptor occupancy does not predict immune activation during pembrolizumab therapy, challenging current dosing ...
A qualitative study of patients with advanced bladder and kidney cancer on immune checkpoint inhibitor therapy finds they want structured ...
A phase 1b study presented at the IASLC 2026 World Conference on Lung Cancer found that subcutaneous tarlatamab was well ...
A systematic review of 75 studies maps how organoids, spheroids, tissue slices, and tumor-on-a-chip systems are being used to test ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine